Supplement Makers Warned on OOS Handling, Recordkeeping

Drug Industry Daily
A A
The FDA has fired off warning letters to two supplement makers over GMP concerns ranging from record handling to incomplete batch production records.

To View This Article:

Login

Subscribe To Drug Industry Daily